|
|
DAP Scoring System in Evaluation of T1 Renal Tumor and Guidance to Surgical Procedures |
QI Ming-jun, WU Xiao-peng, ZHOU Zhong-xin, et al |
Changzhou Second People's Hospital, Jiangsu Province 213000 |
|
|
Abstract 【Objective】To evaluate the DAP scoring system in T1 stage of renal tumor and selection of surgical methods. 【Methods】Data of 92 patients with T1 stage of renal tumor admitted to our hospital were randomly selected for retrospective analysis. According to the DAP scoring system, 92 patients were divided into 3 groups: the low score group (n=18), the medium score group (n=47) and the high score group (n=27). The correlation of surgical methods, surgical parameters and complications were compared among the three groups. 【Results】Data showed that 3 cases in the low score group, 27 cases in the medium score group and 8 cases in the high score group received open surgery; 13 cases in the low score group, 6 cases in the medium score group and 1 case in the high score group had laparoscopic surgery; 1 case in the low score group, 15 cases in the medium score group and 18 cases in the high score group had radical nephrectomy. There were differences between surgical selections and DAP scores (P<0.05). The DAP scoring system was correlated with surgical approach, duration of operation, duration of warm ischemia and estimated blood loss (P<0.05). It was not correlated with the length of hospital stay or glomerular filtration rate (P>0.05). The incidence of complications was not related to age, body mass index, location of onset and duration of warm ischemia (P>0.05). It was correlated with operation mode, operation duration, blood loss and DAP system score (P<0.05). 【Conclusion】The clinical application of DAP scoring system in patients with T1 renal tumor is helpful for the selection of clinical treatment methods and valuable for clinical prediction of perioperative outcomes.
|
Received: 06 November 2018
|
|
|
|
|
[1] 杜和喜, 周骏, 梁朝朝. DAP肾肿瘤评分系统的可信度和可重复性研究[J].现代泌尿生殖肿瘤杂志, 2016, 8(5):260-263. [2] 王仪春, 潘婷, 朱琳,等. 肾部分切除术解剖学特征评估的研究进展[J].中国肿瘤外科杂志, 2015, 7(5):315-324. [3] 付德来, 万紫妍, 张亚萍,等. 单位肾脏体积GFR评价T1期肾肿瘤对GFR的影响[J].新疆医科大学学报, 2017, 40(11):1396-1398. [4] 顾硕. 两种保留肾单位术式治疗T1a期肾癌的临床疗效比较[J].医学临床研究, 2017, 34(8):1518-1520. [5] 李光明, 唐艳华, 康素海,等. T1 期肾癌部分切除术前和术后随访MRI检查的临床价值[J].医学影像学杂志, 2016, 26(2):288-291. [6] 吴朝阳, 余琦, 申智勇. 肾脏部分切除手术对T1a期肾癌患者肾脏的影响[J].中国现代医学杂志, 2016, 26(9):81-84. [7] 孙晓忠, 李绍东. T1期肾透明细胞癌的ADC值、rADC值与Fuhrman病理分级的相关性[J].海南医学, 2017, 28(17):2838-2842. [8] 宋文斌. EU:机器人辅助腹腔镜下肾部分切除术治疗肾细胞癌的术后五年评估[J].现代泌尿外科杂志, 2016, 21(2):151. [9] 朱江, 张生军. 肾细胞癌患者肾切除术前放射学和术后病理学测得肿瘤大小差异的比较分析[J].现代肿瘤医学, 2017, 25(20):3268-3270. |
|
|
|